Regulation & Policy

Is it up to Amazon to make sure what's on the label is what's inside the bottle? ©Getty Images - batuhan toker

From the editor's desk

Is it Amazon’s job to fix a problem that was decades in the making?

By Hank Schultz

There has long been a tale within the dietary supplement business of there being two industries, the ‘good guys’ and ‘them.’ With the proliferation of fraudulent products for sale online, the question becomes, whose job is it to remedy that?

What's happening in the UK & EU for CBD?

What's happening in the UK & EU for CBD?

By Stephen Daniells

With the UK and the European Union now on divergent paths because of Brexit, what is the state of play for regulating hemp and CBD across the pond and where are the opportunities?

NPA Fabricant on CBD, NDIs, FDA resuming inspections

NPA Fabricant on CBD, NDIs, FDA resuming inspections

By Stephen Daniells

FDA has stated it is making ‘substantial progress’ with CBD, and a new enforcement guidance could be very significant for the industry, said NPA’s Dr Daniel Fabricant, but he said the Agency needs to ‘get in the game’ for NDIs.

© Getty Images / ayo888

AGA issues guidelines for probiotics for sick, at-risk populations

By Stephen Daniells

The American Gastroenterological Association has released guidelines for a range of conditions, with strong support for necrotizing enterocolitis in infants and for the prevention of C. difficile infection in adults and children who take antibiotics.

Follow us

Products

View more

Webinars